Las Vegas, NV, Nov. 01, 2017 (GLOBE NEWSWIRE) —
GB Sciences, Inc. (OTCQB: GBLX) inducts a Scientific Advisory Board to provide oversight for product development within GB Sciences’ intellectual property portfolio, consisting of three original patent applications, one licensed patent application, and one licensed approved patent. GB Sciences remains committed to discovering novel cannabis-based therapies for disease-specific applications; as well as producing standardized patent-pending formulations and ensuring their efficacy through well-controlled clinical trials. The Scientific Advisory Board will be tasked with efficiently managing GB Sciences’ resources while creating and testing their proprietary cannabis-based formulas.
The Scientific Advisory Board will be chaired by Dr. Andrea Small Howard, Chief Science Officer of GB Sciences, Inc. “We are very honored to welcome some new members to our Scientific Advisory Board this year; as well as, Dr. Helen Turner, who has worked with GB Sciences for the past four
... read more at: https://globenewswire.com/news-release/2017/11/01/1172035/0/en/GB-Sciences-Inducts-Scientific-Advisory-Board-Dr-Andrea-Small-Howard-of-GB-Sciences-Dr-Helen-Turner-of-Chaminade-University-Dr-Norbert-Kaminsky-of-Michigan-State-University-and-Dr-.html